Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?
Related Questions
When do you consider ultrahigh-dose methylcobalamin injections for ALS?
What is your approach to light sedation in pediatric EMG?
How do you counsel patients with dermatomyositis on sun protection?
How do you approach sequentially tapering combination therapy (i.e., IVIG, mycophenolate, rituximab) for dermatomyositis that is in remission?
Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?
Beyond fatigability, what distinctive features of diplopia characterize myasthenia gravis?
How do you counsel patients with mild congenital myopathy about exercise limitations?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
How do you identify patients with false positive AcHR antibodies?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
